InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Explore the full record of transactions filed by Adcock Richard, Chairman & CEO. Director active across 1 company, notably ImmunityBio, Inc.. Cumulatively, 6 filings have been published. Split: 2 buys · 0 sell. Total volume traded: €109. History available since 9 September 2021. The latest transaction was filed on 5 February 2022 (Levée d'options). Regulator: SEC (Form 4). All data is free.
Declarations6 total
83,333 shares0Common StockSEC:0001326110-22-000006:0
83,333 shares0Common StockSEC:0001326110-22-000006
7 shares@ US$9.000.0000% mcap50.0% of flowCommon StockSEC:0001326110-21-000005:0
Ideal exit: 5 Jul 2022 (T+270)
7 shares@ US$9.000.0000% mcap100.0% of flowCommon StockSEC:0001326110-21-000005
Ideal exit: 5 Jul 2022 (T+270)
8,620 shares0Common StockSEC:0001209191-21-055785:0
8,620 shares0Common StockSEC:0001209191-21-055785
6 of 6 declarations
About Adcock Richard
Richard Adcock is the Chief Executive Officer of ImmunityBio, Inc. As CEO, he leads the company and is responsible for overall strategy and operations. His leadership is essential for the development and growth of ImmunityBio. Richard Adcock has extensive experience in the medical sector, enabling him to make informed decisions to guide the company towards success.
